中草药  2017, Vol. 48 Issue (4): 653-656
0
  PDF    
鸡冠花止血有效部位化学成分研究
冯程1, 石朗2, 陈大忠1, 张洪财1, 赵润琴2     
1. 黑龙江中医药大学中医药研究院, 黑龙江 哈尔滨 150040;
2. 黑龙江中医药大学附属第一医院, 黑龙江 哈尔滨 150040
摘要: 目的 研究鸡冠花Celosia cristata止血有效部位的化学成分。 方法 采用正相硅胶柱色谱、ODS柱色谱和HPLC等方法对其化学成分进行分离、纯化,根据理化性质及波谱数据鉴定化合物结构。 结果 从鸡冠花95%乙醇提取物的醋酸乙酯萃取部位分离得到9个化合物,分别鉴定为northalifoline(1)、韭子碱乙(2)、异鼠李素-3-O-β-D-葡萄糖苷(3)、1-feruloyl-β-D-glucopyranoside(4)、阿魏酸酯6-O-β-D-吡喃葡萄糖酯[5(α构型)、6(β构型)]、2-甲氧基-4-(2-丙烯基)-苯基-β-D-吡喃葡糖苷(7)、羽扇豆醇(8)、阿魏酸(9)。 结论 所有化合物均为首次从鸡冠花植物中分离得到,也均为首次从青葙属植物中分离得到。
关键词: 鸡冠花     止血有效部位     阿魏酸     韭子碱乙     northalifoline    
Chemical constituents of effective part in Celosia cristata for treatment of hemostatic
FENG Cheng1, SHI Lang2, CHEN Da-zhong1, ZHANG Hong-cai1, ZHAO Run-qin2     
1. Research Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin 150040, China;
2. Department of Pharmacy, the First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150040, China
Abstract: Objective To study the chemical constituents of effective fraction in Celosia cristata for hemostatic. Methods The chemical constituents were isolated and purified by chromatography on silica gel, ODS, and preparative HPLC methods. Their structures were determined by physicochemical properties and spectral data. Results Nine compounds have been found in the ethyl acetate fraction of 95% ethanol extraction from C. cristata which were obtained and identified as northalifoline (1), 1,2,3,4-tetrahydro-4-hydroxy-4-quinolin carboxylic acid (2), isorhamnetin-3-O-β-D-glucoside (3), 1-feruloyl-β-D-glucopyranoside (4), Feruloyl 6-O-β-D-glucopyranose ester[5 (α structure), 6 (β structure)], 2-methoxy-4-(2-propenyl) phenyl β-D-glucopyranoside (7), lupeol (8), and ferulic acid (9). Conclusion All compounds are not only isolated from C. cristata for the first time but also from the plants of genus Celosia L. for the first time.
Key words: Celosia cristata L.     effective fraction for hemostatic     ferulic acid     1, 2, 3, 4-tetrahydro-4-hydroxy-4-quinolin carboxylic acid     northalifoline    

鸡冠花为苋科(Amaranthaceae)青葙属Celosia L. 一年生草本植物鸡冠花Celosia cristata L. 干燥花絮,又叫鸡髻花、鸡公花、鸡角枪、鸡冠头、鸡骨子花、老来少等,起源于非洲和亚洲热带地区,在我国已有大面积的种植。据《滇南本草》记载,鸡冠花味苦、微辛,性寒。现代研究表明,其具有止血、抗衰老、调血脂、抗动脉粥样硬化、增强机体抵抗力和免疫力、预防骨质疏松、保肝[1-2]等药理作用,抗疲劳的保健功能以及良好的食疗作用[3-5]。迄今为止,国内外关于鸡冠花的化学成分研究报道较少。本课题组前期对鸡冠花的乙醇提取物依次用石油醚、二氯甲烷、醋酸乙酯、正丁醇进行萃取得到相应的部位及水部位,采用断尾法、毛细玻管法、玻片法测定小鼠凝血时间、血浆复钙时间,检测各部位的止血作用。结果发现醋酸乙酯、正丁醇、水部位组凝血时间与空白组比较,差异有统计学意义;正丁醇和水部位组的血浆复钙时间与空白组比较,差异有统计学意义。确定醋酸乙酯、正丁醇萃取组分均能在一定程度上影响小鼠的出血时间和凝血时间,具有一定的止血作用[6],为鸡冠花止血有效部位。为了合理开发利用鸡冠花这一植物资源,筛选具有止血活性的化合物,本实验对鸡冠花95%乙醇提取物的醋酸乙酯萃取部位进行化学成分研究,从中分离鉴定出9个化合物,分别鉴定为northalifoline(1)、韭子碱乙(1,2,3,4-tetrahydro-4-hydroxy-4-quinolin carboxylic acid,2)、异鼠李素-3-O-β-D-葡萄糖苷(isorhamnetin-3-O-β-D-glucoside,3)、1-feruloyl-β- D-glucopyranoside(4)、阿魏酸酯6-O-β-D-吡喃葡萄糖酯 [feruloyl 6-O-β-D-glucopyranose ester,5(α构型)、6(β构型)]、2-甲氧基-4-(2-丙烯基)-苯基- β-D-吡喃葡萄糖苷 [2-methoxy-4-(2-propenyl) phenyl β-D-glucopyranoside,7]、羽扇豆醇(lupeol,8)、阿魏酸(ferulic acid,9)。所得化合物均为首次从鸡冠花植物中分离得到,也均为首次从青葙属植物中分离得到。

1 仪器与材料

Burker-500型超导核磁共振光谱仪(TMS为内标,瑞士Burker公司);Micro TOF-Q质谱仪(美国Burker公司);Waters 2695-2996型分析型高效液相色谱仪(美国waters公司);Agilent 1100型制备型高效液相色谱仪(美国 Agilent公司);C18反相色谱柱(250 mm×4.6 mm,5 μm,德国Marsh公司);柱色谱用硅胶和薄层色谱用硅胶G(100~200目、200~300目)青岛海洋化工厂有限公司;反相ODS(250 mm×10 mm,10 μm,美国Thermo公司);ZF-I型三用紫外分析仪(上海顾村电光仪器厂);BS124S型电子天平(北京赛多利斯仪器系统有限公司);CP522C型电子天平(奥豪斯仪器有限公司);R-3HB小型旋转蒸发仪(印度BUCHI有限公司);常规试剂均为分析纯。

鸡冠花药材购于黑龙江中医药大学附属第一医院,经黑龙江中医药大学生药学教研室孙慧峰教授鉴定为苋科青葙属植物鸡冠花Celosia cristata L. 的干燥花絮。标本(20150503)保存于黑龙江中医药大学中医药研究院。

2 提取与分离

鸡冠花干燥花序粗粉(14 kg),加8倍量的95%乙醇回流提取3次,每次2 h,合并提取液,减压浓缩得醇提取物。醇提取物用4 L水(低于60 ℃)分散后,放置室温。分别用等体积的石油醚(60~90 ℃)、二氯甲烷、醋酸乙酯依次萃取3次,减压回收溶剂。

醋酸乙酯部位(104.4 g)经硅胶柱色谱,二氯甲烷-甲醇(20∶1→1∶1)梯度洗脱,得到11个组分Fr.A~K。Fr. A(4.29 g)经ODS柱色谱,甲醇-水(1∶4→4∶1)和甲醇梯度洗脱得12个组分Fr.A1-2(37.2mg)、Fr. A3-4(44.1 mg)、Fr. A5-6(23.6 mg)、Fr. A13-14(86.5 mg)、Fr. A15-18(61.4 mg)、Fr. A19-20(53.4 mg)、Fr. A21-22(42.2 mg)、Fr. A23-24(43.5 mg)、Fr. A25-27(36.4 mg)、Fr. A29-31(45.2 mg)、Fr. A32-33(49.7 mg)、Fr. A34-36(39.2 mg);Fr. A1-2经制备HPLC(甲醇-水3∶17)得化合物1(21.7mg)和2(25.5 mg)。Fr. B(10.4 g)经ODS柱色谱,甲醇-水(1∶4→4∶1)和甲醇梯度洗脱得12个组分Fr.B4(49.5mg)、Fr. B7-8(16.8 mg)、Fr. B9-10(14.2 mg)、Fr. B11-14(34.7 mg)、Fr. B22(49.2 mg)、Fr. B29-30(22.4 mg)、Fr. B31-32(27.2 mg)、Fr. B33-34(18.4 mg)、Fr. B35-43(72.0 mg)、Fr. B51-53(18.6 mg)、Fr. B54(31.2 mg)、Fr. B55-56(80.2 mg);Fr. B22结合重结晶方法得化合物3(49.2 mg),Fr. B4经制备HPLC(甲醇-水3∶17)得化合物4(12.0mg)和56(9.0 mg)。Fr. C(5.32 g)经ODS柱色谱,甲醇-水(1∶4→4∶1)和甲醇梯度洗脱得9个组分Fr.C2-5(24.5mg)、Fr. C7-8(16.5 mg)、Fr. C10-12(21.5 mg)、Fr. C13-18(34.2 mg)、Fr. C19(38.5 mg)、Fr. C20-32(51.8 mg)、Fr. C33-39(44.3 mg)、Fr. C40-45(36.7 mg)、Fr. C46-55(32.2 mg);Fr. C19、Fr. C46-55、Fr. C33-39结合重结晶方法分别得化合物7(38.5 mg)、8(45.4 mg)。Fr. E(2.70 g)经ODS柱色谱,甲醇-水(1∶4→4∶1)和甲醇梯度洗脱得7个组分Fr.E7-10(124.2mg)、Fr. E11-12(18.6 mg)、Fr. E15-16(17.4 mg)、Fr. E17-18(16.9 mg)、Fr. E19-21(22.5 mg)、Fr. E22(14.4 mg)、Fr. E25-26(19.0 mg);Fr. E22经制备HPLC(甲醇-水3∶5)得到化合物9(20.0mg)。

3 结构鉴定

化合物1:无色片状结晶(甲醇),mp 140~141℃,HR-MS m/z: 194.062 4 [M+H]+,分子式为C10H11NO3,计算不饱和度为6。1H-NMR (500 MHz,CD3OD) δ: 2.47 (2H,m,H-3),2.79(2H,m,H-4),6.63 (1H,s,H-5),7.32 (1H,s,H-8),3.74 (3H,s,6-OCH3);13C-NMR (125 MHz,CD3OD) δ: 168.9 (C-1),41.1 (C-3),28.4 (C-4),102.8 (C-5),151.0 (C-6),145.3 (C-7),114.8 (C-8),121.2 (C-9),133.7 (C-10),57.0 (6-OCH3)。以上数据与文献报道[7-8]一致,故鉴定化合物1为northalifoline。

化合物2:白色粉末(甲醇),mp 325~328℃,HR-MS m/z:194.198 5 [M+H]+,分子式为C10H11O3N,计算不饱和度为6。1H-NMR (500 MHz,CD3OD) δ: 3.58 (2H,t,J =7.3 Hz,H-2),2.14 (2H,m,H-3),7.32 (1H,d,J = 7.5 Hz,H-5),7.05(1H,m,H-6),7.24 (1H,m,H-7),6.87 (1H,d,J = 7.8 Hz,H-8);13C-NMR (125 MHz,CD3OD) δ:58.4 (C-2),41.2 (C-3),76.4 (C-4),125.1 (C-5),123.6 (C-6),130.5 (C-7),111.2 (C-8),142.6 (C-9),132.7 (C-10),182.0 (C-11)。以上数据与文献报道[9]一致,故鉴定化合物2为韭子碱乙。

化合物3:黄色粉末(甲醇),mp 190~192℃,HR-MS m/z:479.126 8 [M+H]+,分子式为C22H22O12,计算不饱和度为12。1H-NMR (500 MHz,CD3OD) δ: 6.18 (1H,d,J =2.0 Hz,H-6),6.38 (1H,d,J = 2.0 Hz,H-8),7.91 (1H,brs,H-2′),6.89(1H,d,J = 8.4 Hz,H-5′),7.57 (1H,brd,J = 8.4 Hz,H-6′),4.82 (1H,d,J = 7.2 Hz,H-1″),3.23 (1H,m,H-2″),3.45 (1H,m,H-3″),3.40 (1H,m,H-4″),3.45 (1H,m,H-5″),3.55 (1H,m,H-6″a),3.72 (1H,m,H-6″b);13C-NMR (125 MHz,CD3OD) δ:158.4 (C-2),135.3 (C-3),179.4 (C-4),163.1 (C-5),99.8 (C-6),166.0 (C-7),94.7 (C-8),158.6 (C-9),105.7 (C-10),123.1 (C-1′),115.9 (C-2′),148.4(C-3′),150.8 (C-4′),114.3 (C-5′),123.8 (C-6′),103.6 (C-1″),75.9 (C-2″),78.0 (C-3″),71.4 (C-4″),78.5 (C-5″),62.5 (C-6″)。以上数据与文献报道[10]一致,故鉴定化合物3为异鼠李素- 3-O-β-D-葡萄糖苷。

化合物4:白色粉末(甲醇),mp 201~203℃,HR-MS m/z:357.103 6 [M+H]+,分子式为C16H20O9,计算不饱和度为7。1H-NMR (500 MHz,CD3OD) δ: 7.18 (1H,brs,H-2),6.80(1H,d,J = 8.2 Hz,H-5),7.08 (1H,brd,J = 8.2 Hz,H-6),6.38(1H,d,J = 15.9 Hz,H-7),7.71 (1H,d,J = 15.9 Hz,H-8),4.84(1H,d,J = 7.6 Hz,H-1′),3.36~3.55 (4H,m,H-2′,3′,4′,5′),3.62 (1H,m,H-6′a),3.86 (1H,m,H-6′b),3.88 (3H,s,3-OCH3);13C-NMR (125 MHz,CD3OD) δ:127.5 (C-1),111.8 (C-2),149.3 (C-3),150.9 (C-4),114.7 (C-5),124.3 (C-6),148.2 (C-7),116.5 (C-8),167.7 (C-9),103.6 (C-1′),74.0 (C-2′),78.0 (C-3′),71.1 (C-4′),78.7 (C-5′),62.3 (C-6′),56.4 (3-OCH3)。以上数据与文献报道[11]一致,故鉴定化合物4为1-feruloyl-β-D-glucopyranoside。

化合物5(α构型)、6(β构型):白色粉末(甲醇),mp 202~204 ℃,HR-MS m/z: 357.102 8 [M+H]+,分子式为C16H20O9,计算不饱和度为7。1H-NMR (500 MHz,CD3OD) δ: 7.17 (1H,brs,H-2),6.80 (1H,d,J = 8.2 Hz,H-5),7.06 (1H,brd,J = 8.2 Hz,H-6),7.62 (1H,d,J = 15.9 Hz,H-7),6.36 (1H,d,J = 15.9 Hz,H-8),4.50 (1H,d,J = 7.8 Hz,H-β-1′),3.14 (1H,dd,J = 7.8,10.2 Hz,H-β-2′),3.33 (1H,m,H-β-3′),3.58 (1H,m,H-β-4′),3.36 (1H,m,H-β-5′),4.32(1H,dd,J = 11.8,5.4 Hz,H-β-6′a),4.42 (1H,dd,J = 11.8,2.3Hz,H-β-6′b),5.09 (1H,d,J = 3.6 Hz,H-α-1′),3.35 (1H,m,H-α-2′),3.68 (1H,m,H-α-3′),3.38 (1H,m,H-α-4′),3.33 (1H,m,H-α-5′),4.29 (1H,dd,J = 12.0,5.1 Hz,H-α-6′a),4.47 (1H,dd,J = 12.0,3.5 Hz,H-α-6′b),3.88 (3H,s,3-OCH3);13C-NMR (125 MHz,CD3OD) δ:126.8 (C-1),111.6 (C-2),148.3 (C-3),149.3 (C-4),116.4 (C-5),124.1 (C-6),146.9 (C-7),114.9 (C-8),169.1 (C-9),98.2 (C-β-1′),76.2 (C-β-2′),77.9(C-β-3′),70.8 (C-β-4′),75.4 (C-β-5′),64.8 (C-β-6′),94.0 (C-α-1′),73.8(C-α-2′),74.7 (C-α-3′),71.7 (C-α-4′),72.0 (C-α-5′),64.8 (C-α-6′),56.4 (3-OCH3)。以上数据与文献报道[12]一致,故鉴定化合物56为阿魏酸酯-6-O-α/β-D-吡喃葡萄糖酯。

化合物7:白色粉末(甲醇),mp 117~119℃,HR-MS m/z: 327.137 2 [M+H]+,分子式为C16H22O7,计算不饱和度为6。1H-NMR (500 MHz,CD3OD) δ: 6.81 (1H,brs,H-3),6.76 (1H,brd,J = 8.3 Hz,H-5),7.07 (1H,d,J = 8.3 Hz,H-6),3.46 (2H,dd,J = 8.3,1.6 Hz,H-7),5.94 (1H,m,H-8),5.01 (1H,d,J= 18.5 Hz,H-9a),5.04 (1H,d,J = 18.5 Hz,H-9b),4.84 (1H,d,J= 7.6 Hz,H-1′),3.32~3.59 (4H,m,H-2′,3′,4′,5′),3.66 (1H,m,H-6′a),3.85 (1H,brd,J= 11.9 Hz,H-6′b),3.82 (3H,s,2-OCH3);13C-NMR (125 MHz,CD3OD)δ: 146.3 (C-1),150.7 (C-2),114.1 (C-3),136.4 (C-4),122.0 (C-5),118.2 (C-6),40.7 (C-7),138.99 (C-8),115.8 (C-9),103.0 (C-1′),74.9 (C-2′),78.1 (C-3′),71.3 (C-4′),77.8 (C-5′),62.4 (C-6′),56.6 (2-OCH3)。以上数据与文献报道[13]一致,故鉴定化合物7为2-甲氧基- 4-(2-丙烯基)-苯基-β-D-吡喃葡萄糖苷。

化合物8:无色粉末(甲醇),mp 173~174℃,HR-MS m/z: 492.431 2 [M+H]+,分子式为C23H24O12,计算不饱和度为12。1H-NMR (500 MHz,CD3OD) δ:6.33 (1H,d,J = 2.0 Hz,H-6),6.61 (1H,d,J = 2.0 Hz,H-8),7.93 (1H,d,J = 2.0 Hz,H-2′),6.90 (1H,d,J = 8.4 Hz,H-5′),7.62 (1H,dd,J = 8.4,2.0 Hz,H-6′),5.21 (1H,d,J = 7.4 Hz,H-1″),3.42 (1H,m,H-2″),3.30 (1H,m,H-3″),3.44 (1H,m,H-4″),3.21 (1H,m,H-5″),3.72 (1H,dd,J = 12.0,2.2 Hz,H-6″a),3.55 (1H,dd,J = 12.0,5.5 Hz,H-6″b),3.94(3H,s,3′-OCH3),3.88 (3H,s,4′-OCH3);13C-NMR (125 MHz,CD3OD) δ: 151.1 (C-2),135.4 (C-3),179.5 (C-4),159.0 (C-5),100.0 (C-6),167.3 (C-7),93.0 (C-8),158.4 (C-9),106.7 (C-10),122.9 (C-1′),114.3 (C-2′),148.4 (C-3′),151.1 (C-4′),116.0(C-5′),123.9 (C-6′),103.4 (C-1″),75.9 (C-2″),77.8 (C-3″),71.5 (C-4″),78.5(C-5″),62.5 (C-6″),56.8 (3′-OCH3),55.1 (4′-OCH3)。以上数据与文献报道[14]一致,故鉴定化合物8为羽扇豆醇。

化合物9:白色粉末(甲醇),mp 170~171℃,HR-MS m/z:193.163 1 [M-H]+,分子式为C10H10O4,计算不饱和度为6。1H-NMR (500 MHz,CD3OD) δ: 7.18 (1H,brs,H-2),6.80 (1H,d,J = 8.4 Hz,H-5),7.06 (1H,brd,J = 8.4 Hz,H-6),6.38 (1H,d,J = 16.0 Hz,H-7),7.71 (1H,d,J = 16.0 Hz,H-8),3.84 (3H,s,3-OCH3);13C-NMR (125 MHz,CD3OD) δ:127.7 (C-1),111.9 (C-2),148.3 (C-3),149.3 (C-4),114.6 (C-5),124.3 (C-6),147.1 (C-7),116.5 (C-8),167.5 (C-9),56.4 (3-OCH3)。以上数据与文献报道[11]一致,故鉴定化合物9为阿魏酸。

参考文献
[1] 张炯炯, 徐领城, 施卉. 鸡冠花药用价值实验研究概述[J]. 中国药业, 2006, 15(9):25–26.
[2] Wang Y, Lou Z, Wu Q B, et al. A novel hepatoprotective saponin from Celosia cristata L[J]. Fitoterapia, 2010, 81(8): 1246–1252. DOI:10.1016/j.fitote.2010.08.011
[3] 张声生, 陈贞, 许文君, 等. 基于"寒、热、虚、实"二次辨证的565例功能性消化不良证候分布特点的研究[J]. 中华中医药杂志, 2008, 23(9):833–835.
[4] 赵显, 包贝华, 张丽, 等. 鸡冠花研究进展[J]. 中国医药信息杂志, 2012, 19(2):100–102.
[5] 徐守霞. 鸡冠花中黄酮类化合物的研究进展[J]. 宁波职业技术学院学报, 2009, 13(5):104–107.
[6] 石朗, 杜冰, 张婷婷, 等. 鸡冠花不同提取部位止血作用研究[J]. 医药导报, 2013, 32(9):1122–1124.
[7] Jun L, Nan H K, Joo W N, et al. Scopoletin from the flower buds of Magnolia fargesii inhibits protein glycation, aldose reductase, and cataractogenesis ex vivo[J]. Arch Pharm Res, 2010, 33(9): 1317–1323. DOI:10.1007/s12272-010-0904-z
[8] 谢宇, 胡金刚, 洪小伟, 等. 异喹啉酮类衍生物的合成研究[J]. 有机化学, 2010, 30(6):894–897.
[9] 桑圣民, 毛士龙, 劳爱娜, 等. 中药韭子中一个新生物碱成分[J]. 天然产物研究与开发, 2000, 12(2):1–3.
[10] Huang H C, Hwang S Y, Liang Y H, et al. Constituents from taiwanese sarcopyramis nepalensis[J]. J Chin Med, 2013, 24(1): 1–12.
[11] Kim J S, Kwon Y S, Sa Y J, et al. Isolation and identification of Sea Buckthorn (Hippophae rhamnoides) phenolics with antioxidant activity and r-glucosidase inhibitory effect[J]. J Agric Food Chem, 2011, 59(1): 138–144. DOI:10.1021/jf103130a
[12] Brigida D A, Antonio F, Andreina R, et al. Structural characterization and radical scavenging activity of monomeric and dimeric cinnamoyl glucose esters from Petrorhagia velutina leaves[J]. Phytochem Lett, 2010, 3(1): 38–44. DOI:10.1016/j.phytol.2009.11.001
[13] Kei S, Yoko K, Tomohisa N. Biotransformation of thymol, carvacrol, and eugenol by cultured cells of Eucalyptus perriniana[J]. Phytochemistry, 2006, 67(20): 2256–2261. DOI:10.1016/j.phytochem.2006.07.006
[14] Jihan M B. Chemical constituents of Phragmanthera austroarabica A. G. Mill and J. A. Nyberg with potent antioxidant activity[J]. Pharmacognosy Res, 2015, 7(4): 335–340. DOI:10.4103/0974-8490.158436